Revenue and profitability highlights:
- Revenue: USD 4,113,722,000; YoY growth 11.08%; QoQ growth 3.80%
- Gross Profit: USD 3,707,822,000; Gross Margin: 90.13% (grossProfit/Revenue). Note: The margin metric appears unusually high given typical hospital service models; interpret with caution due to potential data construct anomalies. QoQ gross profit growth: 3.78%; YoY gross profit growth: 1019.52% (reported in data, likely base-effect artifact).
- Operating Income: USD 472,489,000; Operating Margin: 11.49% (OperatingIncome/Revenue).
- Net Income: USD 332,397,000; Net Margin: 8.08%.
- EPS: USD 5.07 basic; USD 4.96 diluted; QoQ/EPS growth: YoY 58.93%; QoQ 30.33%.
- EBITDA: USD 623,953,000; EBITDA Margin: ~15.17% (EBITDA/Revenue).
- Net cash flow and capex: CFO USD 658,437,000; Capex USD 245,945,000; Free Cash Flow USD 412,492,000.
Balance sheet and liquidity:
- Total assets: USD 14,469,749,000; Total liabilities: USD 7,706,933,000; Total stockholders’ equity: USD 6,666,207,000.
- Cash and cash equivalents: USD 125,983,000; Cash at end of period: USD 224,752,000.
- Total debt: USD 4,955,429,000; Net debt: USD 4,829,446,000.
- Current ratio: 1.274; Quick ratio: 1.174; Cash ratio: 0.0570.
- Leverage and coverage: Debt to capitalization 0.426; Debt to equity 0.743; Interest coverage 11.78x.
Capital allocation and returns:
- Free cash flow per share: USD 6.29; Operating cash flow per share: USD 10.04.
- Dividends paid: USD 13.0 million; Dividend yield (reported): ~0.11%.
- Price/earnings: 8.86x; Price/book: 1.77x; Price/sales: 2.87x; EV/EBITDA: 26.58x.
Notes on comparability and data integrity: Several margin metrics shown (notably gross margin) appear unusually high for a hospital operator and may reflect data labeling or reporting conventions in the provided dataset. Where margins appear anomalous, the underlying revenue and cost figures have been cited to aid interpretation, but readers should cross-check with the company’s official 10-K/10-Q filings for confirmation.